General
Preferred name
CENTHAQUINE
Synonyms
PMZ-2010 ()
Centhaquin ()
Centhaquine, PMZ-2010 ()
CENTHAQUINE CITRATE ()
PMZ2010 ()
COMPOUND-7173 ()
Centhaquina ()
Lyfaquin ()
PMZ2010 CITRATE ()
PMZ-2010 citrate ()
P&D ID
PD132800
CAS
57961-90-7
Tags
available
drug candidate
Drug Status
investigational
Max Phase
1.0
3.0
Drug indication
Shock
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Centhaquine (Centhaquin; PMZ-2010) is a novel agent has the potential for treatment of haemorrhagic shock. Centhaquine (Centhaquin; PMZ-2010) can augment cardiac output, reduce systemic vascular resistance in haemorrhagic models[1][2].
PRICE 69
DESCRIPTION Centhaquin is a new type of drug with the potential to treat hemorrhagic shock. (BOC Sciences Bioactive Compounds)
DESCRIPTION Centhaquin (Centhaquine)e is an adrenergic receptor potentially for the treatment of postoperative pain and for the resuscitation of hypovolemic shock (TargetMol Bioactive Compound Library)
Compound Sets
10
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
24
Properties
(calculated by RDKit )
Molecular Weight
331.2
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
4
Aromatic Ring Count
3
cLogP
3.91
TPSA
19.37
Fraction CSP3
0.32
Chiral centers
0.0
Largest ring
6.0
QED
0.72
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
analgesic agent
Target
Hypotensive agent
Source data